StockWatch
·
Pharmaceuticals
Quarterly Result11 Feb 2026, 12:31 pm

Alpa Laboratories Approves Q3 Financial Results with Limited Review Report

AI Summary

Alpa Laboratories Limited has approved the un-audited standalone and consolidated financial results for the quarter ended on 31st December, 2025. The approval came during a Board Meeting held on 11th February, 2026. The financial results were reviewed by the independent auditor, C.H. Padliya & Co., and found to be in compliance with the Indian Accounting Standards and other applicable accounting principles.

Key Highlights

  • Alpa Laboratories approved the un-audited standalone and consolidated financial results for Q3 2025.
  • The approval was given during a Board Meeting held on 11th February, 2026.
  • The financial results were reviewed by the independent auditor, C.H. Padliya & Co.
  • The results were found to be in compliance with the Indian Accounting Standards and other applicable accounting principles.
  • The meeting commenced at 11:00 AM and concluded at 12:05 PM.